Isosorbide dinitrate clinical studies: Difference between revisions

Jump to navigation Jump to search
Pratik Bahekar (talk | contribs)
No edit summary
GeraldChi (talk | contribs)
 
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Isosorbide dinitrate#Clinical Studies]]
{{Isosorbide dinitrate}}
{{CMG}}; {{AE}} {{PB}}
 
==Clinical Trials==
 
In clinical trials immediate-release oral ISDN has been administered in a variety of regimens, with total daily doses ranging from 30 mg to 480 mg. Controlled trials of single oral doses of ISDN have demonstrated effective reductions in exercise-related angina for up to 8 hours. [[Anti-anginal]] activity is present about 1 hour after dosing.
 
Most controlled trials of multiple-dose oral ISDN taken every 12 hours (or more frequently) for several weeks have shown statistically significant [[anti-anginal]] efficacy for only 2 hours after dosing. Once-daily regimens, and regimens with one daily dose-free interval of at least 14 hours (e.g., a regimen providing doses at 0800, 1400, and 1800 hours), have shown efficacy after the first dose of each day that was similar to that shown in the single-dose studies cited above. The effects of the second and later doses have been smaller and shorter-lasting than the effect of the first.
 
From large, well-controlled studies of other nitrates, it is reasonable to believe that the maximal achievable daily duration of [[anti-anginal]] effect from ISDN is about 12 hours. No dosing regimen for ISDN, however, has ever actually been shown to achieve this duration of effect. One study of 8 patients, who were administered a pretitrated dose (average 27.5 mg) of immediate-release ISDN at 0800, 1300, and 1800 hours for 2 weeks, revealed that significant [[anti-anginal]] effectiveness was discontinuous and totaled about 6 hours in a 24 hour period.
 
 
<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = ISORDIL (ISOSORBIDE DINITRATE) TABLET [BTA PHARMACEUTICALS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=abb3ad49-73a8-49c5-adc5-164d052971d7 | publisher =  | date =  | accessdate = 30 January 2014 }}</ref>
 
==References==
 
{{Reflist|2}}
 
[[Category:Drugs]]

Latest revision as of 22:40, 21 July 2014